Grand is Managing Director, RCT Ventures and head of MedTech Innovator. Prior to joining RCT, Grand was co-founder and VP Operations of Imagine Pharmaceuticals, which developed a platform to selectively deliver therapeutics and other compounds across the blood brain barrier. He was also co-founder and CEO of MicroSurgeon, which developed a microwave thermal ablation device for the treatment of solid tumors. Grand has extensive experience in new company formation and fund raising. Since 1990, he has built, operated, recruited management and raised financing for eight high technology, medical device and biotechnology companies. Grand also was a Managing Director for Fruition Ventures, a group of private equity investors focused primarily on tech companies. Grand is actively involved in programs to encourage bio-entrepreneurship, innovation and commercialization of early stage technologies. He has lectured, judged business plans, and mentored students and scientists at numerous universities, including UCLA, Stanford, USC, and UCSF. Grand serves as an investment advisor to the LARTA NIH Commercialization Assistance Program for SBIR program awardees. He is on the Oversight Committees for the Coulter Translational Research Partnership Programs at USC and University of Washington. Grand is a reviewer for proof of concept and commercialization-focused funding programs for the University of California system-wide, USC, University of Utah and University of Colorado. Grand is a frequent panelist at biomedical conferences. He has spoken at more than 100 conferences, been featured in hundreds of articles in publications including Forbes, New York Times and Wall Street Journal and appeared as an expert on Bloomberg Television, CNN, and CNN/FN. Grand is head of the MedTech Innovator competition and accelerator, designed to foster transformative innovation that benefits patients and delivers improved value to the health care system. - http://medtechinnovator.com

Managing Director @ Responsible for investment activities for Research Corporation Technologies (RCT), a $300+ million investment firm focused in the life sciences. Currently, Paul is focused on medical device opportunities. From January 2005 to Present (10 years 11 months)

Paul Grand is skilled in: Venture Capital, Start-ups, Biotechnology, Medical Devices, Pharmaceutical Industry, Commercialization, Corporate Development, Lifesciences, Technology Transfer, Licensing, Due Diligence, Patents, Mergers, Financial Modeling, Entrepreneurship